[ Price : $8.95]
FDA releases the form FDA-483 with three observations from an inspection at Indias Eugia Pharma Specialties Limited.[ Price : $8.95]
FDA proposes not to include semaglutide, tirzepatide, and liraglutide on the 503 Bulks List of drugs that can be legally compounde...[ Price : $8.95]
The CDER Office of Prescription Drug Promotion cautions Bayer that a video and TV ad for its Nubeqa omit important risk informatio...[ Price : $8.95]
Five Hogan Lovells attorneys discuss ways in which life sciences companies can use artificial intelligence in drug development and...[ Price : $8.95]
The U.S. House Appropriations Committee votes to approve a spending bill to fund FDA for fiscal year 2027.[ Price : $8.95]
FDA approves an expanded use for Axsome Therapeuticss Auvelity (dextromethorphan hydrobromide and bupropion hydrochloride) to trea...[ Price : $8.95]
An FDA advisory committee votes 6 to 3 against supporting AstraZenecas investigational breast cancer therapy camizestrant.[ Price : $8.95]
Following a reported patient death, FDA places a hold on new patient enrollment at U.S. sites participating in ENIGMA-TRS 2 study,...